2015 American Transplant Congress Archives - Page 113 of 170

Damage Associated Molecular Patterns (DAMPs)-Activated Neutrophil Extracellular Trap Formation Exacerbates Liver Ischemia/Reperfusion Injury

H. Huang, S. Tohme, A. Al-Khafaji, A. Tsung.
Day of Week Influences Kidney Utilization

K. Foley, M. Chiles, S. Mohan.
De Novo Donor Specific Antibody (DSA) After Treatment of BK Infection With Intravenous Immunoglobulin (IVIG)

J. Kahwaji, P. Wongsaroj, J. Choi, A. Peng, R. Villicana, S. Jordan, A. Vo.
De Novo Donor-Specific HLA Antibodies After Kidney Transplantation Are Associated With Donation After Circulatory Death and HLA-DQ Mismatch

G. Dreyer,¹ D. Roelen,² S. Brand-Schaaf,² O. Dekkers,³ M. Reinders,¹ F. Claas,² J. de Fijter.¹
De Novo DSA Would Not Necessarily Cause Graft Rejection After Renal Transplantation: Characteristics of DSA Developing Biopsy-Proven Chronic Antibody-Mediated Rejection

T. Yamamoto, Y. Watarai, A. Takeda, M. Okada, M. Tsujita, H. Takahisa, N. Goto, S. Narumi, T. Kobayashi.
De Novo Once-Daily Tacrolimus in Liver Transplantation: Long-Term Outcomes of a Single Center Cohort of 150 Patients

M. Gastaca, A. Valdivieso, J. Bustamante, P. Ruiz, J. Fernandez, A. Ventoso, M. Testillano, I. Palomares, P. Salvador, M. Prieto, A. Matarranz, M. Suarez, J. Ortiz de Urbina.
Deceased Donor and Class II Donor Specific Antibody Predict Interface Activity While Increased Age at Time of Biopsy Predicts Fibrosis in Long-Term Pediatric Liver Allografts With Normal Liver Tests: iWITH Clinical Trial

S. Feng,¹ J. Bucuvalas,² A. Demetris,³ K. Spain,⁴ G. Mazariegos,³ B. Burrell,⁵ iWITH Investigators.⁶
Deceased Donor HLA Antibody Incompatible Renal Transplantation Without Antibody Removal: High Incidence of Acute Rejection Reduced By T-Cell Depleting Induction Therapy

E. Jolly,¹ C. Taylor,² H. Morgan,² S. Peacock,² M. Clatworthy,¹ N. Torpey.¹
Deceased Donor Kidney Transplantation Without Calcineurin Inhibitors or Steroids

A. Kirk,^1,2 A. Guasch,¹ S. Mead,¹ A. Ghali,¹ A. Mehta,¹ H. Gebel,¹ R. Bray,¹ C. Larsen,¹ T. Pearson.¹
Declaring a Patient Brain Dead on Extracorporeal Membrane Oxygenation (ECMO): Are There Guidelines or Misconceptions?

K. Kreitler,¹ N. Cavarocchi,¹ H. Hirose,¹ S. West,² R. Hasz,² M. Ghobrial,³ R. Bell.³
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of Graft Failure and Mortality Among Kidney Transplant Recipients

P. Clayton,^1,2,3 W. Lim,^1,4 S. Chadban.^1,2,3
Decline in Living Donor Rates Pervasive Across All Kidney Transplant Candidate Groups

G. Vranic, A. Nishio Lucar, D. Keith.
Decreased Expression of Mitochondrial Aldehyde Dehydrogenase 2 Induces Liver Injury Via Activation of the MAPK Pathway in Grafts from Brain-Dead Donors

Z. Zhong,¹ S. Ye,¹ Y. Xiong,¹ X. Fan,¹ W. Huang,¹ D. Ko,³ Y. Wang,¹ Q. Ye.^1,2
Deep Surgical Site Infections (dSSI) After Liver Transplantation (LTx): Emergence of Multiple-Drug Resistant (MDR) Pathogens

J. Viehman,¹ L. Clarke,¹ R. Shields,² C. Clancy,^2,3 M. Nguyen.^1,2
Deficiency of Naturally Occurring Anti-Angiogenic Antibodies Associate With the Development of Metastatic Cancer Post Renal Transplantation and Patient Death

R. Carroll,¹ A. Phillippe,² R. Catar,² H. Heidecke,² D. Dragun.²
Defining and Directing T Cell Subsets Involved in Rejection of Vascularized Composite Allografts

M. Fryer, G. Furtmùller, B. Oh, S. Reddy, K. Sarhane, G. Raimondi, G. Brandacher, D. Cooney.
Defining the Epidemiologic Landscape of HIV-Infected Deceased Donors in the United States

A. Cash, A. Shaffer, S. Anjum, A. Massie, D. Segev, C. Durand.
Defining the Role of CD57+CD4 T Cells in Belatacept-Resistant Rejection

J. Espinosa,^1,2 L. Stempora,^1,2 R. Townsend,³ A. Kirk.^1,2
Delayed Graft Function (DGF) in Kidney Transplant Recipients (KTRs) Is Associated With Early Allograft Inflammation and Progressive Fibrosis Within 3 Months

A. Cherukuri, R. Mehta, P. Sood, S. Chen, G. Mour, A. Tevar, P. Randhava, S. Hariharan.
Delayed Graft Function in Patients Receiving Alemtuzumab Induction Therapy

M. Shindorf,¹ D. Fumo,¹ M. Weis,¹ W. Qu,¹ M. Rees,^1,2 J. Ortiz.¹
Delayed Kidney Transplant in Combined Liver-Kidney Transplantation Improves GFR and Patient Survival

B. Ekser, W. Goggins, R. Mangus, S. Nagai, C. Kubal, J. Fridell, S. Kinsella, J. Powelson, A. Tector.
Delayed Tacrolimus (TAC) to Rapamycin (RAPA) Conversion in Renal Transplant Recipients With DGF/SGF

A. Haririan,¹ D. Klassen,¹ M. Keshtkar,¹ C. Drachenberg,² T. Dowling,³ E. Ramos,¹ R. Ugarte,¹ C. Cangro,¹ M. Weir.¹
Deleterious Effects in Kidney Transplant Outcomes With Pre-Organ Procurement Iodine Contrast Exposure

F. Barrantes,¹ S. Stith.²
Delivery of Heme Oxygenase-1-Cell Penetrating Peptide (HO-1-CPP) Into Hepatocytes, Kupffer and Islet Cells in In Vitro and Ex Vivo Models of Cold Ischemia

A. Venkatachalam,¹ C. Wood,¹ Q. Hu,¹ I. Alwayn.²
Dendritic Cells in Kidney Transplant Biopsies Are Associated With Poor Allograft Survival

I. Batal,¹ S. De Serres,¹ K. Safa,¹ A. Waaga,¹ M. Onozato,² N. Najafian,¹ A. Chandraker.¹
Dengue Virus Infection Among Renal Transplant Recipients: A Series of 10 Cases in a Tropical Country

S. Costa,^1,2 C. Jacinto,¹ L. Martiniano,¹ Y. Amaral,¹ F. Paes,² M. Sales,² E. Daher,^1,2 G. Junior,³ R. Esmeraldo.²
Depression of Complement Regulatory Factors in Human and Rat Renal Grafts in Association With Progress of Acute Cellular Rejection

K. Yamanaka,^１ T. Kato,^１ Y. Kakuta,¹ T. Abe,¹ R. Imamura,¹ A. Maeda,² S. Miyagawa,² N. Nonomura.¹
DEPTOR Is Expressed in CD4+ T Cells and Modulates Effector Responses and Allograft Rejection

J. Wedel, S. Bruneau, K. Liu, N. Kochupurakkal, M. Laplante, D. Briscoe.
Dermatology Is an Essential Part of Transplant Care: Report of a Two-Year Experience from a Transplant Dermatology Center

E. Pritchett,¹ B. Miller,¹ A. Colasacco,¹ G. Malat,² A. Doyle,² S. Guy,³ C. Cusack,¹ C. Chung,¹ M. Abdelmalek.¹
Descriptive Analysis of Patients Who Travel Away from Home for Orthotopic Liver Transplantation

C. Frenette,¹ A. Harper,³ J. Waalen,² J. Fisher,¹ R. Schaffer,¹ A. Baquerizo,¹ C. Marsh.¹
Desensitization Before Living Donor Kidney Transplantation in Highly Sensitized Patients

E. De Sousa,¹ I. Revuelta,¹ M. Blasco,¹ F. Diekmann,¹ J. Cid,² M. Lozano,² A. Sánchez-Escuredo,¹ J. Martorell,³ E. Palou,³ J. Campistol,¹ F. Oppenheimer.¹
Desensitization Protocol Including Concomitant Bortezomib and Rituximab Did Not Reduce Calculated PRA Nor Mean MFI Values Among Waitlisted Patients for Deceased Donor Kidney Transplantation

S. Kang,¹ H. Lim,¹ J. Jeong,¹ E. Song,² I. Yun,³ C. Ahn,¹ J. Yang.¹
Desensitization With Costimulation Blockade and Proteasome Inhibition in a Non-Human Primate Model of Kidney Transplantation

C. Burghuber,^1,2 J. Kwun,¹ E. Page,¹ A. Gibby,¹ F. Leopardi,³ A. Farris,¹ N. Iwakoshi,¹ S. Knechtle.^1,3
Designing a KDPI to Assess Live Donors and Compare Them to Deceased Donors

A. Massie, D. Segev.
Detecting Bowel Cancer in Pre-Dialysis, Dialysis Patients and Kidney Transplant Recipients – The DETECT Study

G. Wong, J. Chapman, J. Craig.
Detection of Donor Specific HLA-Ab (DSA) Against Native HLA Molecules Expressed On Donor Cell Surface to Eliminate False Positive DSA in Luminex Single Antigen Beads (LMX-SAB)

G. Chen, L. Lin, D. Tyan.
Detection of Donor-Specific Anti-HLA Antibodies Is Associated With Changes in the Peripheral Distribution of NK Cell Subsets in Kidney Allograft Recipients

M. Crespo,¹ D. Redondo,¹ J. Yelamos,² A. Muntasell,² M. Pérez-Sáez,¹ M. Lopez-Montañes,³ C. Garcia,⁴ A. Torío,⁵ J. Hernandez,⁴ M. Mir,¹ M. Lopez-Botet,³ J. Pascual.¹
Detergent-Sonication Method for the Whole Laryngeal Decellularization

N. Nayakawde,¹ K. Methe,¹ M. Berg,² G. Premaratne,¹ H. Ejnell,² M. Olausson.¹
Determinants and Sequelae of Hepatic Artery Thrombosis After Liver Transplantation: A Registry Study of Recipient Diagnosis and Coagulopathy

J. Garonzik Wang,¹ M. Doyle,¹ K. Collins,¹ J. Lowell,¹ Y. Lin,¹ S. Shenoy,¹ J. Wellen,¹ W. Chapman,¹ D. Segev.²
Determinants of Accelerated CAV in Heart Allografts: Major Independent Impact of Circulating DSA

M. Bories, Varnous, Guillemain, Suberbielle, Jouven, Bruneval, Duong, Loupy.
Detriemental Impact of DGF and CIT On Longterm Survival After Kidney Transplantation in Elderly Recipients

C. Denecke,^1,2 M. Biebl,^1,2 C. Bösmüller,² F. Aigner,^1,2 T. Dziodzio,^1,2 R. Sucher,^1,2 S. Weiss,² J. Pratschke,^1,2 R. öllinger.^1,2
Development and Validation of a Genotype Guided Tacrolimus Dosing Equation for African American (AA) Kidney Transplant Recipients

K. Sanghavi,¹ R. Brundage,¹ M. Miller,² D. Schaldt,³ A. Israni,³ W. Guan,⁴ W. Oetting,¹ R. Mannon,⁵ R. Remmel,¹ A. Matas,⁶ P. Jacobson.¹
Development of a Post-Graduate Year 2 Solid Organ Transplant Pharmacy Residency Program at an Academic Medical Center

A. Guyton, D. Clark, M. Todd, J. Peterson, A. James.
Development of a Risk Assessment Model for HIV Among Increased Risk Deceased Donors With Negative Nucleic Acid Testing

P. Annambhotla, B. Gurbaxani, M. Kuehnert, S. Basavaraju.
Development of a Targeted Genetic Renal Disease Panel With NexGen Sequencing for Unbiased Testing of Living Kidney Donors for Genetic Kidney Disease

C. Thomas,¹ Z. Stewart,³ A. Mansilla,² S. Mason,² A. Kwitek,² C. Campbell,² R. Smith,^1,2 R. Smith.^1,2
Diabetes Exacerbates Liver Ischemia and Reperfusion Injury By Activating the AGE-RAGE Pathway in Kupffer Cells

S. Yue, J. Zhu, J. Rao, J. Kupiec-Weglinski, R. Busuttil, Y. Zhai.
Diabetes Mellitus and Prediabetes On Kidney Transplant Waiting List – Prevalence, Metabolic Phenotyping and Risk Stratification Approach

M. Guthoff,¹ D. Vosseler,¹ J. Langanke,¹ S. Nadalin,² A. Königsrainer,² H.-U. Häring,¹ A. Fritsche,¹ N. Heyne.¹
Diabetes Mellitus Predicts Outcome in Obesity After Kidney Transplantation

T. Schachtner,^1,2 P. Reinke.^1,2
Diabetic Kidney Transplant Recipients: Impaired Infection Control and Alloreactivity

T. Schachtner,^1,2 M. Stein,² P. Reinke.^1,2
Dialysis Facility Kidney Transplant Referral in Georgia: 2005-2012

S. Pastan,¹ J. Gander,¹ L. Plantinga,¹ L. Sauls,² E. Gibney,³ L. Mulloy,⁴ J. Krisher,² R. Patzer.¹
Dietary-Associated Trimethylamine N-Oxide (TMAO) Levels Is associated With Coronary Allograft Vasculopathy Following Heart Transplantation

S. Zeltzer,¹ Z. Wang,¹ M. Askar,² J. Coughlin,¹ T. Hudec,¹ D. Taylor,³ L. Li,¹ R. Starling,³ S. Hazen,¹ W. Tang.¹
Differences in Genetic Variants That Influence Long-Term Graft Function Between Pancreas Transplant Donors and Recipients

M. Simmonds,¹ C. Duff,¹ A. Hamilton,¹ S. Mittal,^2,3,4 M. Barnardo,^2,3 S. Fuggle,^2,3 P. Friend,^2,3 S. Gough.^1,4
Differences in Reactivity of HLA-Specific Antibodies May Be Explained By Differences in Their Affinities for Selected Epitopes on HLA Proteins

S. Daga,^1,2 D. Lowe,⁶ R. Buchli,⁵ J. Collard,⁵ A. Mulder,⁸ C. McMurtrey,^4,5 H. Moyse,⁷ N. Evans,⁷ N. Krishnan,² W. Hildebrand,^4,5 F. Claas,⁸ D. Briggs,³ D. Zehnder,^1,2 D. Mitchell,¹ R. Higgins.^1,2
Differential Clinical Outcomes in Kidney Transplant Recipients With De Novo C1q+ and C1q- Donor Specific Antibodies

M. Ajaimy,¹ A. Colovai,² S. Calp,¹ J. Lindower,¹ M. Melamed,³ E. Akalin.¹
Differential Expression and Function of ASC and Nlrp3 Inflammasome Adaptors in Hematopoietic Stem Cells (HSCs)

A. Scheinok, R. Elahimehr, A. Shigeoka, S. Kasimsetty, D. McKay.
Differential Intragraft Gene Expression Profiles in Patients With Sterile Leukocyturia

M. Ajaimy,¹ P. O Broin,² Y. Bao,¹ J. Lindower,¹ A. Golden,² E. Akalin.¹
Differential Role of PI3K Subunits Gamma and Delta in Regulatory T Cells Homeostasis in Allotransplantation

J. Azzi, M. Uehara, Z. Solhjou, P. Lukyanchykov, A. Radwan, L. Riella, R. Abdi.
Differentially Expressed Genes in Immunosuppressed Kidney Transplant Recipients

C. Dorr,¹ B. Wu,² W. Guan,² A. Muthusamy,¹ K. Sanghavi,³ P. Jacobson,³ W. Oetting,³ D. Schladt,¹ R. Remmel,³ J. Maltzman,⁵ A. Matas,⁴ For DeKAF Genomics Investigators,¹ A. Israni.¹
Differentially Expressed IL-6Rα and GP130 Genes in Kidney Biopsies (Bxs) Suggests Different Roles of IL-6 Signaling in Antibody (ABMR)- and Cell (CMR)-Mediated Rejection

H. Zhang,¹ D. Thomas,¹ J. Kowalewska,² E. Suviolahti,¹ H. Shafi,² C. Nast,² A. Gertych,² A. Vo,¹ M. Haas,² S. Jordan,¹ M. Toyoda.¹
Diminished Survival After Simultaneous Liver-Kidney Transplant With Increasing Kidney Donor Profile Index Score

C. Jay, G. Halff, G. Abrahamian, K. Washburn.
Discard of Kidneys at the Margin: ECD Versus KDPI Era

S. Bae, A. Massie, D. Segev.
Discrepancies Between the U.S. Transplant Registry and Cancer Registries Regarding Cancer Diagnoses in Transplant Recipients

E. Engels,¹ D. Segev,² J. Snyder,³ B. Kasiske,³ E. Yanik.¹
Disparities in Death and Delisting on the Waitlist for Renal Transplant in the United States

D. Keith, A. Nishio Lucar, G. Vranic.
Distal Splenorenal Shunt (DSRS): A Durable Bridge to Liver Transplantation

J. Pomposelli, A. Tongyoo, R. Jenkins, M. Akoad, W. Lewis, E. Pomfret.
Distinct Blood and Biopsy Meta-Signatures for Acute Rejection Post Kidney Transplant

W. Zhang,¹ Z. Yi,¹ Z. Li,¹ M. Menon,¹ L. Li,¹ C. Xi,¹ I. Greene,¹ C. Wei,¹ L. Gallon,² M. Samaniego,³ A. Djamali,⁴ S. Alexander,⁵ B. Schroppel,¹ B. Nankivell,⁵ J. Chapman,⁵ I. Rosales,⁶ R. Neal Smith,⁶ R. Colvin,⁶ P. O'Connell,⁵ P. Heeger,¹ B. Murphy.¹
Distinct Clinical Relevance of BAFF Expression Within the Kidney Graft and Soluble BAFF Serum Levels Indicate Confined Alloimmune Responses Disconnected from the Periphery

E. Campos,^1,2 K. Mine,¹ A. Goncalves-Primo,^1,2 M. Soares,⁴ M. Franco,² J. Medina-Pestana,^2,3 H. Tedesco-Silva,³ M. Gerbase-DeLima.^1,2
Distinct Role of Complement Receptors C5L2 and C5aR in Acute Kidney Injury and Renal Fibrosis

A. Thorenz,¹ R. Chen,¹ K. Hüper,³ B. Hensen,³ C. Klemann,⁵ M. Meier,⁴ A. Klos,² F. Güler.¹
Distinct Roles of CD137 and CD137L Bi-Directional Signaling in Candida albicans Infection

H. Cho,^1,2 J. Lee,^2,3 V. Tran,⁴ B. Kwon.^2,4
Distinct Subtypes of Rejection in a Novel Non Human Primate Model of Sensitization

C. Burghuber,^1,2 J. Kwun,^1,3 F. Leopardi,³ A. Gibby,¹ A. Farris,¹ N. Iwakoshi,¹ S. Knechtle.^1,3
Distinctive Roles of mTORC1 Vs. mTORC2 in Liver Ischemia-Reperfusion Injury

H. Zhou,^1,2 J. Zhu,^1,3 S. Yue,¹ M. Zhang,³ R. Busuttil,¹ Q. Xia,³ J. Kupiec-Weglinski,¹ Y. Zhai.¹
Divergence in Risk Factors for Graft Loss and Death Across Race May Mediate Kidney Transplant Outcome Disparity

M. Posadas Salas,¹ D. Taber,² M. Kamel,¹ M. Kadian,¹ M. Salazar,¹ P. Mohan,¹ T. Srinivas.¹
Diverticulitis in Immunosuppressed Patients – A Fatal Outcome Requiring a New Approach?

A. Brandl, T. Kratzer, E. Braunwarth, S. Weiss, M. Maglione, S. Schneeberger, R. Kafka-Ritsch.
DNA Methylation Classifier Associates With Long-Term Graft Function Post-Kidney Transplantation

J. Suh,¹ D. Maluf, K. Archer,² T. Lee,¹ L. Gallon,³ V. Mas.¹
DNA Methylation of the IFNγ Promoter in CD8+ T Cell Subsets Is Modulated by CMV Infection but not by Alloreactivity in Kidney Transplantation Patients

K. Boer,¹ E. de Wit,¹ L. Hofland,² M. Betjes,¹ C. Baan.¹
DNA Methytransferase 1 Inhibition Potently Suppresses T Cell Cycle Progression Through Demethylation of the Key Cell Cycle Inhibitors p15, p16, p21 and p27

T. Ma, Y. Pei, R. Tao.
Do CMS Oversight and the Systems Improvement Agreement Really Change Institutional Behavior?

C. Hoopes.
Do Community-Solicited NDDs Experience More Coercion to Donate a Kidney Than Traditional NDD Donors?

D. Serur, G. Bretzlaff, P. Christos, F. Desrosiers, M. Charlton.
Do Induction Therapy, Patient-Level and Post-Operative Factors Impact Outcomes in Moderate to High Immunologic Risk Simultaneous Kidney-Pancreas Transplantation in the Era of Stringent HLA Cross-Matching?

V. Rohan, D. Taber, D. Taraskiewicz, S. Nadig, J. Mcgillicuddy, K. Chavin, P. Baliga, C. Bratton.
Do Pre-Procurement Factors Affect Vascular Resistance During Pulsitile Perfusion of Deceased Donor Kidneys?

H. Kay,¹ S. Gates,² P. Shragg,² L. Stocks,² D. McKay,² R. Steiner.²
Does a History of Diabetes in Deceased Donors Modify the Outcomes of Kidney Transplant Recipients With Diabetes?

T. Rajan, J. Kim.
Does BMI Affect Survival in Cadaveric Liver Transplantation for Benign Conditions?

S. Ayloo, S. Hurton, M. Cwinn, R. Kavanagh, M. Molinari.
Does DSA Market Competition Influence OPO Performance?

J. Adler,¹ H. Yeh,¹ J. Markmann,¹ L. Nguyen,² D. Axelrod.³
Does Higher Cost Improve Outcome in Pediatric Liver Transplantation?

J. Minneman, J. Grijalva, S. Rangel, H. Kim, K. Vakili.
Does HLA-Incompatible Transplantation Confer a Survival Advantage in the UK?

M. Manook,¹ Z. Ahmed,¹ R. Johnson,² O. Shaw,¹ N. Kessaris,¹ A. Dorling,¹ N. Mamode.¹
Does Infection Impact On Tacrolimus Blood Levels in Kidney Transplant Recipients?

N. Kanaan,¹ C. Percy,¹ Z. Hassoun,² M. Mourad,³ C. Beguin,⁴ M. De Meyer,³ E. Goffin.¹
Does Prophylaxis Strategy Matter? CMV Reactivation in Moderate Risk (R+) Heart Transplant Recipients

E. Liu, C. Doligalski.
Does PTH Play a Role in Post Kidney Transplant Leukopenia?

R. Dhawan, L. Shin, K. Lee, B. Duong, L. Aguirre, C. Parke, S. Alexopoulos, M. Smogorzewski, A. Gomez, E. Mariscal, L. Matsuoka, Y. Qazi.
Does Pulmonary Rehabilitation Impact Frailty?

C. Kennedy,¹ P. Novotny,² N. LeBrasseur,³ R. Wise,⁴ F. Sciurba,⁵ R. Benzo.¹
Does Smoking Lead to Increased Rates of Acute Cellular Rejection in Liver Transplant Recipients?

B. Rao,¹ D. Montezuma-Calvo,² K. Tosch,² S.-M. Jafri.²
Does Switching Predict Conversion: IgM De Novo Donor Specific HLA Antibodies Class Switch to IgG in Subclinical Antibody Mediated Rejection in Heart Transplant Recipients

M. Askar,¹ R. Rodriguez,¹ L. Klingman,¹ D. Thomas,¹ A. Zhang,¹ H. Morf,² N. Hamon,¹ N. Moazami,¹ E. Hsich,¹ D. Taylor,¹ R. Starling,¹ C. Tan.¹
Does the C1q Assay Predict the Result of Lymphocyte Flow Cross-Match (FCxM) in Potential Renal Transplant Recipients With HLA-DSA and AHG-CDC CxM negative?

J. Arreola-Guerra, A. de Santiago, A. Arvizu, N. Gonzalez-Tableros, M. Lopez, M. Vilatoba, L. Morales-Buenrostro, J. Alberu, N. Castelan.
Does the Site Or Etiology of Renal Artery Stenosis Influence the Sucess Rate of Percutaneous Transluminal Angioplasty?

A. Bull, W. Nahas, K. Yamaçake, R. Kato, I. Antonopoulos, H. Kanashiro, G. Ebaid, A. Piovesan.
Does Transversus Abdominis Plane Block Reduce Opioid Analgesic Requirements in the Post-Operative Period in Renal Transplant Recipients?

F. Afridi,¹ R. Coates,¹ S. Wright,² J. French,¹ D. Talbot,¹ S. Rita.²
Does Ureteric Stent Avoid Urological Complications After Renal Transplantation? A Retrospective Study of 10 Years Experience

R. Kato, W. Nahas, K. Yamaçake, H. Kanashiro, R. Falci, A. Bull, I. Antonopoulos, G. Messi, A. Piovesan.
Domino Liver Transplant from Donors With MSUD: Operative Strategy and Long-Term Outcomes

B. Kelly,¹ K. Soltys,¹ G. Bond,¹ J. Vockley,² K. Strauss,³ H. Morton,³ R. Sindhi,¹ G. Mazariegos.¹
Donor Age and Late Rejection Are Associated With the Development of Graft Coronary Artery Vasculopathy in Pediatric Heart Transplant Recipients

W. Zuckerman, M. Richmond, T. Lee, L. Addonizio.
Donor and Recipient Pretransplant Polyoma BK Serostatus: Relationship to BK-Viremia After Renal Transplantation

H. Tseng, R. Lopez-Soler, N. Chandolias, T. Friedrich, J. Eldor, D. Conti.
Donor Apolipoprotein L1 Genotype Associates With Glomerular Lesions and Graft Loss in Kidney Transplants

T. Srinivas, P. Baliga, K. Chavin, M. Gebrezhiaber, L. Egede, D. Taber.
Donor CD47 Plays a Critical Role in the Control of Alloreactive T Cell Activation Following Hepatocyte Transplantation

M. Zhang,^1,2 H. Wang,¹ N. Navarro-Alvarez,¹ Y. Zheng,² Y.-G. Yang.¹
Donor Derived Transmission Events in 2014: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

D. Kaul,¹ S. Covington,² S. Taranto,² M. Green,¹ C. Wolfe.¹
Donor Hemodynamic Profile Presages Graft Survival in Donation After Cardiac Death Liver Transplantation

M. Ertreo, C. Desai, R. Girlanda, T. Frias, T. Fishbein.
Donor Lung Preservation With the Organ Care System® Promotes a Tissue Protective and Anti-Inflammatory Response During Transplantation

B. Wiegmann,¹ C. Falk,² M. Seyda,² C. Neudörfl,² A. Akhdar,² C. Kühn,¹ I. Tudorache,¹ M. Avsar,¹ A. Haverich,¹ G. Warnecke.¹
Donor MHC Independent Rejection of Islet Allografts in Autoimmune NOD Mice

A. Burrack,¹ K. Beard,² M. Coulombe,² R. Gill.²
Donor Microbiota and Its Contribution for the Development of Primary Graft Dysfunction Following Human Lung Transplantation

Z. Xu,¹ R. Schuessler,¹ N. Steward,¹ R. Hachem,² E. Trulock,² A. Patterson,¹ D. Kreisel,¹ T. Mohanakumar.¹
Donor Obesity Impact on Simultaneous Kidney-Pancreas Transplantation Outcomes

T. Alhamad,¹ A. Malone,¹ H. Chakkera.²
Donor Organ Resident M2 Type Myeloid Cells Protect Murine Orthotropic Liver Transplants from Ischemia and Reperfusion Injury

S. Yue, X. Shen, F. Gao, R. Busuttil, J. Kupiec-Weglinski, Y. Zhai.
Donor Selection and Prophylactic IVIg for Induction Immunosuppression Improves Outcomes for HIV+ Kidney Transplant Recipients (HIV+ Tx)

G. Malat,^1,2 L. Panarey,³ A. Sharma,³ K. Ranganna,³ D. Reich,² G. Xiao,² A. Doyle.³
Donor Serum and Urine Proteomic Signatures Differentiate Between Immediate and Delayed Graft Function in Kidney Transplantation

M. Kaisar,^1,2 H. Huang,^1,2 Z. Akhtar,¹ H. Leuvenink,³ B. Kessler,² R. Ploeg.¹
Donor Specific Antibodies (DSA) Increase the Risk for Rejection After Pancreas Transplantation Qithout Negatively Impacting Survival

M. Marquez, M. Dib, G. Sapisochin, J. Laurence, A. Barbas, F. Bazerbachi, A. Norgate, M. Selzner, P. Greig, I. McGilvray, M. Cattal.
Donor Specific Expansion of Regulatory T-Cells Was Associated With Allograft Tolerance Induced By Transient Mixed Chimerism in Nonhuman Primates

K. Hotta, A. Aoyama, T. Ohura, M. Tonsho, Y. Yamada, J. Allan, J. Madsen, B. Cosimi, G. Benichou, T. Kawai.
Donor Specific Tolerance Can Be Induced by Donor Bone Marrow Transfer With Activation of Invariant Naturel Killer T Cells

S. Miyairi,¹ T. Hirai,¹ R. Shibahara,¹ K. Omoto,¹ S. Nunoda,² K. Yamazaki,² Y. Ishii,³ K. Tanabe.¹
Donor-Derived Cell-Free DNA Is Stable in Non-Rejecting Heart Transplant Recipients in the CARGO II Multicenter Trial

D. Hiller,¹ M. Grskovic,¹ J. Beausang,¹ R. Sit,¹ B. Christie,¹ J. Elechko,¹ R. Woodward,¹ J. Yee,¹ H. Eisen.²
Donor-Derived Tumor Transmission Events. A Summary of 2008-2013 Data from the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

M. Nalesnik,¹ S. Taranto,² S. Covington,² E. Blumberg,¹ M. Green,¹ T. Gross,¹ M. Klassen-Fischer,¹ M. Pavlakis,¹ C. Wolfe,¹ D. Kaul.¹
Donor-Specific Alloantibody After Positive Crossmatch Kidney Transplantation With Eculizumab (EC): Correlation With Transplant Glomerulopathy and Graft Failure

C. Schinstock,¹ F. Cosio,¹ L. Cornell,¹ M. Gandhi,¹ M. Everly,² M. Stegall.¹
Donors at Age Extremes for Simultaneous Pancreas-Kidney Transplant (SPKT)

A. El-Hinnawi, R. Pelletier, E. Elkhammas, A. Rajab, G. Bumgardner, R. Plews, T. Pesavento, U. Nori, M. Henry.
Down-Regulation of Autophagy Correlates With Increased Apoptosis in the Kidney, But Not in the Liver, of Brain Dead Rats

A. van Erp,¹ R. Rebolledo,³ P. Ottens,¹ J. Pirenne,² H. Leuvenink,¹ J.-P. Decuypere.²
DQB1 Epitope Matching Predicts the Development of De Novo DSA and Antibody Mediated Rejection

M. Willicombe,¹ M. Blow,² P. Brookes,² E. Santos,² D. Taube.¹
Dramatic Improvements in Racial Disparities in Kidney Transplant Outcomes in the US

T. Purnell,¹ X. Luo,¹ L. Kucirka,¹ L. Cooper,¹ A. Massie,¹ D. Crews,¹ L. Boulware,² D. Segev.¹
Dramatic Primary Expansion of Indirect CD4 T Cells to Allogeneic APCs In Vivo

N. Bishop,¹ M. Nelsen,¹ M. Coulombe,² R. Gill.²
DSA Detected by ELISA-PRA Is Associated With High Risk for Development of AMR in Stable Kidney Transplant Recipients

D. Lee,¹ J. Kim,² B. Kim,³ M. Chun,⁴ I. Kim.⁵
DSA MFI Does Not Predict Late Antibody-Mediated Rejection Lesions Or Gene Expression Changes in Kidney Transplants

L. Hidalgo,¹ J. Venner,² P. Halloran.²
DSA Monitoring in Kidney Transplant Recipients

F. Pean,¹ M. Cooper,¹ J. Verbesey,¹ A. Gilbert,¹ B. Javaid,¹ R. Mohammed,¹ O. Timofeeva,² J. Moore,¹ K. Cruz,¹ R. Ghasemian,¹ T. Fishbein,¹ M. Grafals.¹
Dual Induction Therapy With Anti-Thymocyte Globulin and Basiliximab in Simultaneous Pancreas-Kidney Transplantation Reduced Incidence of Acute Rejection

K. Miki, K. Iwadoh, I. Nakajima, S. Fuchinoue.
Dual Kidney Transplantation – Utilising Marginal Kidneys

T. Rana, E. Ablorsu.
Dual PI3K-mTOR Inhibition on Human T Cell Activation, Proliferation, and Differentiation: The First Step in the Development of New Immunosuppressants

V. Vilchez,¹ A. Castellanos,¹ D. Butterfield,³ M. Mitov,³ C. Hoopes,¹ F. Marti,² R. Gedaly.¹
Durability of Pancreatic Islets Transplantation in Brittle Type 1 Diabetics- 10 Year Follow Up

Z. Tekin,¹ L. Schenck,¹ M. Garfinkel,⁵ L. Philipson,² J. Thistlethwaite,¹ W. Chon,² K. Golab,¹ O. Savari,¹ S. Ramachandran,¹ K. Rezania,³ S. Hariprasad,⁴ J. Millis,¹ P. Witkowski.¹